New Progress in the Molecular Regulations and Therapeutic Applications in Cardiac Oxidative Damage Caused by Pressure

Xiaomeng Shi1, Arin Dorsey1, Hongyu Qiu1

  • 1Center for Molecular and Translational Medicine, Institute of Biomedical Science, Georgia State University, Atlanta, GA 30303, USA.

Insights

Oxidative stress contributes to heart failure from chronic pressure overload. This review details reactive oxygen species, antioxidant defenses, and new therapies for pressure-induced heart damage.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Pathophysiology

Background:

  • Chronic pressure overload is a major cause of mortality, leading to heart failure.
  • The molecular mechanisms underlying pressure-overload-induced heart failure are not fully understood.
  • Oxidative stress is implicated in the development of cardiac dysfunction.

Purpose of the Study:

  • To review the role of oxidative stress in pressure-overload-induced cardiomyopathy.
  • To explore the mechanisms of reactive oxygen species production and antioxidant defenses in the stressed heart.
  • To summarize preclinical therapeutic strategies for pressure-overload-induced myocardial damage.

Main Methods:

  • Literature review of recent advancements in understanding oxidative stress in heart failure.
  • Focus on biological sources of reactive oxygen species (ROS) and antioxidant systems.
  • Analysis of studies on cardiac metabolic remodeling and therapeutic approaches in animal models.

Main Results:

  • Oxidative stress, driven by specific ROS sources, plays a critical role in cardiac dysfunction.
  • Imbalances in antioxidant defenses contribute to the pathogenesis of pressure-overload-induced cardiomyopathy.
  • Cardiac metabolic remodeling is closely associated with oxidative stress in the stressed heart.

Conclusions:

  • Enhanced understanding of oxidative stress mechanisms is crucial for treating hypertensive heart failure.
  • Targeting oxidative stress pathways offers potential for novel therapeutic strategies.
  • Preclinical findings suggest promising avenues for managing pressure-overload-induced myocardial damage.

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
822
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
67
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
72
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
751